What is it about?
The authors reviewed the latest developments regarding these important diagnostic tools in Alzheimer’s disease discussing laboratory assays available and clinical implications for the near future.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
These diagnostic tools have been gaining a lot of importance in the field of Alzheimer’s disease because they can speed up the early diagnosis of cases before the onset of clinical symptoms and without the need for an expensive investigation. This dynamic field is currently facing numerous changes and this review discuss the most important developments and the impact they will have in the clinics.
Perspectives
The future of Alzheimer’s disease is going to be revolutionized by blood and plasma-based biomarkers. Early diagnosis and early treatment will be a reality worldwide in the near future.
Marcos Pais
Read the Original
This page is a summary of: Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice, Journal of Alzheimer s Disease Reports, May 2023, IOS Press,
DOI: 10.3233/adr-230029.
You can read the full text:
Contributors
The following have contributed to this page
